The silicone breast implant evolved over subsequent decades (Table 1 ), yet despite these advances, adverse outcomes such as capsular contracture led to a U.S. Food and Drug Administration moratorium on silicone breast implant use in the United States in 1992, other than for investigational purposes. The moratorium was lifted in 2006, permitting the use of silicone implants for primary breast augmentation.
As a condition of approval, the U.S. Food and Drug Administration mandated follow-up of silicone device performance through Core Studies. [3] [4] [5] [6] [7] [8] [9] The goals of the Core Gel Studies are to provide evidence-based results over 10 years from evaluation of patients with silicone breast implants from different manufacturers. Three-to 10-year followup is now available from the three major implant manufacturers.
The most common complications following primary breast augmentation include capsular contracture, implant malposition, rippling, and seroma. Because reports of capsular contracture rates range from 2 to 45 percent of patients, there is often lack of clarity in complication rate reporting in the literature. [10] [11] [12] [13] [14] [15] The data are also confounded by multiple variables, including cohorts ranging from single-surgeon series to meta-analyses, different techniques incorporating subglandular versus submuscular placement, and different implant texturing methods from different manufacturers. (Table 2 ). Gylbert's Breast Augmentation Classification system is comparable to the Baker scale, but the opinion of the patient is not included.
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Although the causes of capsular contracture are multifactorial, the leading theory points toward subclinical implant infection with Staphylococcus epidermidis from mammary ducts.
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Biofilm formation and blood in the breast pocket, contributing iron as a source of bacterial nutrient, have also been described. 24, 25 Results of a higher incidence of capsular contracture with smooth implant surface in the subglandular position have been reproducible in several studies, suggesting that implant physical properties such as surface may also contribute to capsular contracture. 26, 27 Textured implants, particularly in the submuscular position, have been associated with the lowest rates of capsular contracture. 28, 29 Current implant textured surfaces use a number of different techniques to create microscopic pores in the surface of silicone implants. Theoretically, this leads to physical disruption of surrounding capsular tissue. The efficacy of surface texturing in reducing capsules may derive from interruption of parallel collagen fiber orientation during capsular formation around a breast implant. [30] [31] [32] [33] This has been repeatedly studied in clinical series, randomized controlled trials, Core Gel Studies, and meta-analyses. 26, 27, [34] [35] [36] [37] [38] [39] [40] [41] [42] Allergan (Allergan, Inc., Irvine, Calif.), Mentor (Mentor Corp., Santa Barbara, Calif.), and Sientra (Sientra, Inc., Santa Barbara, Calif.) have all received approval from the U.S. Food and Drug Administration for clinical use of textured breast implants. Since these companies use markedly different techniques for the formation of their respective textured implant surfaces, the purpose of this article is to summarize these differences and the long-term outcome data reported by the manufacturers and individual clinical studies to provide a single summary of the complication rates.
This article compiles the three major manufacturers' data for capsular contracture, malposition, seroma, and rippling for silicone implants from the Core Studies. Although rippling rates have been reported to be higher in a single surgeon's series of textured implants, this has not been substantiated in studies with higher levels of evidence with multiple surgeons and increased numbers of patients.
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Double capsules and late seromas have also been reported. [43] [44] [45] A discussion of manufacturer differences in textured implant surfaces, form-stable implants, and the impact on complications is presented. New concepts, including tissue friction coefficient, that may influence malposition after primary breast augmentation, are also presented.
PATIENTS AND METHODS
A literature search of PubMed and the Cochrane Library was performed to obtain the most updated data from silicone breast implant Core data studies. The following key words were used for the literature search: core, silicone implant, augmentation mammaplasty, capsule, capsular contracture, breast, complication, texture, seroma, and rippling. Authoritative Web sites were also reviewed for Core data retrieval. 46 Data were extracted; entered into a Microsoft (Microsoft Corp., Redmond, Wash.) Excel spreadsheet; and separated for Mentor, Allergan, and Sientra. Bar graph figures were generated to demonstrate Core Study complication rates over a 10-year period following primary breast augmentation with silicone implants. Only verifiable data from each manufacturer were included (Figs. 2 through 7) for a side-by-side trend comparison of different manufacturer Core data. Table 3 demonstrates Core complication profiles for silicone breast implants from the three major manufacturers. Mentor and Allergan data were recorded separately for round and shaped implant models. These two manufacturers underwent separate U.S. Food and Drug Administration approval processes for their round and shaped silicone implants. Sientra received U.S. Food and Drug Administration approval for their round and shaped breast implants through a single application process, and therefore their data are combined.
RESULTS
Figures 2 through 5 demonstrate key complication rates over a 10-year period following primary breast augmentation. Figure 2 demonstrates an increased trend in capsular contracture rates over time for both round and shaped implants. Because of the reporting differences in the Core data among manufacturers, capsular contracture rates cannot be directly compared. Furthermore, the Core study design also limited the extent of seroma results reported in Figure 3 . Figure 4 summarizes the differences in manufacturer-specific rippling rates. Figure 5 demonstrates a tendency toward reduced malposition with the use of textured, shaped Allergan implants compared with round implants by the same manufacturer. This measure of malposition does not include malrotation of shaped devices. Similar trends cannot be studied for Mentor or Sientra either because of a lack of data acquisition in Core studies, or the combined inclusion of smooth, round, and shaped device data in their cohorts. Therefore, statistical comparison between manufacturers was not possible because of the variability in manufacturer-specific Core study design.
DISCUSSION
A summary of the three U.S. manufacturers' Core Studies of complication profiles for silicone implants, up to 10 years following primary breast augmentation, has been provided. Different implant textures were compared using the following complication rates: capsular contracture, malposition, seroma, and rippling. Although direct comparisons cannot be made, this article serves as a source summary of the largest cohort of longterm data. The advantages and disadvantages of manufacturer-specific texturing processes were correlated with the recently described phenomena of double capsules and late seromas. Lastly, the concept of tissue friction coefficient as it relates to breast implant surgery is discussed. 
Histology of Capsular Contracture
Histologic tissue responses to textured and smooth silicone implant device surfaces contrast with clinical outcomes. 31, 47 Textured implants result in thicker and more inflammatory capsular tissue formation than smooth-surfaced implants, yet despite these findings, clinical comparisons suggest reduced capsular contracture rates with textured implant use. 26, 27, 34, 39, 40, 47 Force vectors around an implant contribute to capsular contracture. 31 Myofibroblasts may contribute to this force production. 30, 48 These cell populations peak during the first week of wound healing in breast capsular tissue and have demonstrated responsiveness to agonists and antagonists of smooth muscle contractility. 30 Because the inflammatory mediator leukotriene triggers smooth muscle contraction in bronchioles, use of antileukotriene agents has been reported to reduce progression of early stages of capsular contracture. 49 In summary, despite histologic findings of thicker and more inflamed capsular tissue around textured implants, textured implants demonstrate reduced capsular contracture rates compared with smooth implants in primary breast augmentation. Capsulotomy has been theorized to be clinically effective because of unloading of myofibroblast tension, resulting in apoptosis and cell death, with improvement in capsular contracture.
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Manufacturer-Specific Texturing Processes
Each manufacturer uses a proprietary texturing process, resulting in differences in texture pore density, diameter, depth, and distribution on the implant surface. All implants undergo an initial process of silicone shell manufacture followed by company-specific processes for surface texturing. 51 Allergan uses a "salt-loss technique" for Biocell macrotexturing. Mentor uses negativecontact polyurethane foam imprinting to produce Siltex microtexturing. 31 Sientra claims proprietary confidentiality for their TRUE Texture technique.
Detailed assessment of textured breast implant surface histology has been performed. 52 Biocell pores demonstrate diameters of 600 to 800 μm, with depths of 150 to 200 μm that are distributed irregularly across the implant's surface. Siltex pores are five times smaller, with a 70-to 150-μm diameter and 40-to 100-μm height. Siltex texturing is more evenly distributed over the surface of the implant. Round Siltex breast implants have 100 pores per inch, whereas shaped Siltex implants have 65 pores per inch. Microscopic architectural description of Sientra's TRUE Texture implant surface has not been released by the manufacturer. Figure 1 demonstrates scanning electron microscopic architectural differences between smooth and textured implant surfaces from the three major manufacturers.
Danino et al. were among the first to examine corresponding capsular architecture surrounding textured surface implants. Biocell's 600-to 800-μm diameter surface pores allowed for mirror-image capsular ingrowth, whereas Siltex's 70-to 150-μm diameter surface pore microtexturing resulted in linear fibrosis of corresponding capsular tissue. 52 Microtexturing and macrotexturing parameters are likely to be more formally defined as implant manufacture evolves and the contribution to surgical outcomes of proprietary processes are better appreciated through more rigorous comparative study.
Improved understanding of pore density, depth, and diameter of microtexturing versus macrotexturing may assist in the appropriate selection of breast implants for use in primary breast augmentation. This concept, combined with the suspected multifactorial causes of capsular contracture, is an important component of an evolving pool of evidence-based medicine. 30, 31, 48, 53, 54 
Cause of Capsular Contracture and Textured Implants
Subclinical implant infection with Staphylococcus epidermidis is a leading cause of capsular contracture. 20, 21, 23 Bacteria can bind to an implant regardless of smooth or textured surface characteristics. 55 Once exposed to an implant, bacteria may form a biofilm through established stages: reversible attachment, irreversible attachment, growth, differentiation, and dissemination. Several studies name bacterial biofilm as a potential cause of breast implant capsular contracture. 19, 25, 57 Other causes of contracture that support the multifactorial hypothesis have been considered: silicone versus saline fill, Seven randomized controlled trials evaluating the impact of surface texture on capsular Pooled data yielded an odds ratio of 0.19 (95 percent CI, 0.07 to 0.52), supporting capsular contracture reduction associated with surface textured implants. Capsular contracture occurred five times more frequently with smooth surface implants in the subglandular plane. Data for submuscular subgroup analysis were derived from a single, underpowered comparative study.
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Nonrandomized studies support the claim of reduced capsular contracture when implants are placed in the submuscular position. 6, 28, 29 The systematic review by Wong et al. included six studies (all included in Barnsley's meta-analysis) demonstrating reduced capsular contracture rates at 1, 3, and 7 years postoperatively with textured devices used in breast augmentation. 27 Although the former studies focused on review of data collected before 2000, Stevens and colleagues offered a more contemporary analysis. 28 Sientra TRUE Texture implants were used for subglandular and submuscular primary breast 4, [6] [7] [8] [9] [63] [64] [65] [66] Hypothetically, the highly cohesive gel exerts counterpressure, expanding the surrounding breast tissue, thereby improving shell incorporation and minimizing capsular contracture formation.
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Figure 2 demonstrates potential reduced capsular contracture with shaped implant use compared with round implant use in primary breast augmentation. A more natural feel has been described with shaped implants because the implant, breast, and capsule move and feel like a natural breast. 8, 66 This is often in contrast to the feel of smooth-surfaced implants that move separately within the pocket from the breast tissue.
Malposition and Shaped Textured Implants
Textured shaped devices minimize the risk of malrotation within the pocket resulting from friction between the implant and the tissue. The concept of "friction coefficient" mentioned by Bengtson in his report of style 410 Core Study results at 3 years is an important concept, as textured implants have a higher tissue friction coefficient than smooth implants. 8 Friction (f) equals the coefficient of friction (µ) multiplied by force (n) pressing two objects together (f = μN).
67
The coefficient of friction (µ) is dependent on the materials used (i.e., glass on ice has a low coefficient of friction, and rubber on cement has a high coefficient of friction). 67 Industry-directed study has determined the coefficient of friction for all three major manufacturers' smooth and shaped implant surfaces (Figs. 6 and 7) . 68 All manufacturers' textured implants demonstrated statistically greater friction coefficients compared with their smooth surface counterparts. Mentor and Allergan demonstrated statistically significant differences in average coefficients of friction for their textured implant surfaces compared with Sientra's textured surface, but not when compared with each other (Fig. 6) . The implant shells of larger Allergan and Sientra shaped implants have reduced coefficients of friction compared with smaller implants from the same manufacturers (Fig. 7) . This is likely because of a reduction in pore density over a larger surface area in the larger implants. This size-dependent phenomenon was not demonstrated between smaller and larger Mentor microtextured devices. Considered together, the results from Figures 5 through 7 are suggestive of the relationship between microtexturing, macrotexturing, and the tissue friction coefficient that may reduce the incidence of malposition. Despite comparable coefficients of friction for Mentor and Allergan shaped devices, microtextured devices demonstrated reduced malposition rates compared with macrotextured devices (Fig. 5) . Precise pocket development to optimize contact between implant surface and surrounding tissue likely contributes to a reduced risk of implant malposition.
Seromas and Textured Implants
Despite the reduction in capsular contracture that textured devices provide, macrotexturing may be responsible for late seroma formation and double capsules.
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"Late seroma" is generally believed to occur more than 1 year after surgery. 63 Spear et al. demonstrated late seroma occurrence at a mean of 4.7 years after surgery. 44 Late seromas have drawn recent attention given the ongoing investigation into their possible relationship with anaplastic large-cell lymphoma.
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Hall-Findlay identified a subset of primary breast augmentation patients who developed late seroma formation and double capsules. 43 Fourteen patients with double capsules were identified, all of whom had macrotextured implants. The cause of the problem was suggested to be mechanical, secondary to forceful separation between aggressively textured implants and their capsule. Microtextured surfaces have also been demonstrated to result in seroma but may have received less attention because of lack of literature support regarding microtextured surface seroma formation and symptomatic double capsules.
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Guidelines for management of late seroma after breast implant placement are available to rule out anaplastic large-cell lymphoma. 45 Both the seroma fluid and capsule tissue should be sent for malignant cytologic and immunohistochemical stains, including CD30 and cytokeratin.
Rippling and Textured Implants
Limited reports suggest that rippling may occur more frequently with the use of textured implants.
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Appropriate patient selection, accounting for adequate soft-tissue coverage through tissue pinch and calculation of body mass index, may minimize this risk. Rippling correlates strongly with body mass index less than 18.5 in primary breast augmentation. Underweight patients demonstrate statistically more frequent rippling with smooth saline implants compared with smooth silicone implants in the subglandular position. 73 Earlier generation silicone implants have less silicone cross-linking and, therefore, less formstability. To be truly form-stable, an implant must maintain its shape, regardless of position. An implant's form-stability may affect how well its superior pole maintains shape and avoids rippling when subjected to gravity in the upright position.
Texture-type also seems to correlate with rippling. Handel et al. noted a significant difference in frequency of skin rippling among breast augmentation cohorts with Biocell (10 percent) compared with Siltex (2.2 percent) textured implants.
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These results complement the understanding that Siltex microtexturing results in a weakly adherent capsule, contrary to the strong adherence and tissue incorporation of Biocell macrotexturing. 43, 54 In cases of revision surgery for capsular contracture after Siltex implant use, Malata et al. found capsules lined with synoviallike fluid. 34 The weakly adherent capsule associated with Siltex devices may be secondary to synovial metaplasia. Synovial metaplasia has not been shown to occur with Biocell implants.
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STUDY LIMITATIONS
With the exception of rippling rates for Mentor round implants, Allergan and Mentor Core data did not report complication rates separately for each surface subtype. This prevented extraction of round, textured implant-specific complication rates for the majority of complications reported in this review, along with valid statistical comparison of these rates among manufacturers. Only complication rate trends were reported in this article. The intention of the article was to offer a consolidated resource referencing 10 years of published Core data. Reported data should be considered in the context of the studies from which they were derived. Manufacturer studies were not set up similarly, and reported results are incomplete, or not specific to textured devices, as shown in Table 3 . Future comparative, randomized trials may validate use of one textured implant over another to minimize complications focused on in this review. Other limitations, inherent in a retrospective review of primary breast augmentation outcomes, include the confounding variables of surgical technique, implant location, and differences in manufacturer texturing processes. Furthermore, this study was primarily limited by reviews of singlesurgeon series, a limited number of meta-analyses/systematic reviews, and Core manufacturer reports.
CONCLUSIONS
This review article describes the fundamental differences in the microscopic surface textures of silicone breast implants with respect to size, depth, and surface area distribution in addition to the techniques used to manufacture the three different surfaces. A summary of the 10-year Core data is presented for ease of comparison. Although no conclusions can be drawn with respect to direct comparison between groups because of the inherent differences in the design of the Core Gel Studies, the incidences of three large cohorts are presented side-by-side in a single reference demonstrating rates of capsular contracture, seroma, and malposition in the largest series available in the literature. These data, despite the limitations, are very important for beginning to recognize potential differences in outcomes and complications based on microtexturing and macrotexturing.
Furthermore, the concept of a textured implant surface's tissue friction coefficient is presented. The coefficient of friction produced by macrotexturing and microtexturing objectively quantifies the level of adherence between the implant and surrounding breast tissue. The clinical relevance relates to differences in tissue and implant adherence by ingrowth, distinct from the friction produced without tissue ingrowth. Potential advantages include reduction in capsular contracture and rotation. Potential disadvantages include surface fragmentation, rippling, and double capsules. 52 Future implant studies should focus on the clinical outcomes associated with implant surface microtexturing compared with macrotexturing used in breast augmentation. Atlanta, Ga. 30318 macodner@gmail.com
